ARTICLE | Finance
Next in line
WuXi NextCODE's $75 million series B could fuel path to IPO
May 6, 2017 1:25 AM UTC
WuXi NextCODE Genomics Inc. could be the final New WuXi Life Science Ltd. subsidiary to head for an IPO.
NextCODE, one of three New WuXi subsidiaries, announced May 1 that it raised $75 million in a series B round co-led by Temasek and Yunfeng Capital, with participation from Amgen Ventures and 3W Partners. ...
BCIQ Company Profiles